Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $22.7 million.

  • Sotera Health's Depreciation and Depletion fell 213.73% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year increase of 516.78%. This contributed to the annual value of $84.3 million for FY2024, which is 1003.3% up from last year.
  • Latest data reveals that Sotera Health reported Depreciation and Depletion of $22.7 million as of Q3 2025, which was down 213.73% from $23.1 million recorded in Q2 2025.
  • Sotera Health's Depreciation and Depletion's 5-year high stood at $23.2 million during Q3 2024, with a 5-year trough of $15.4 million in Q1 2021.
  • In the last 5 years, Sotera Health's Depreciation and Depletion had a median value of $18.9 million in 2023 and averaged $18.8 million.
  • Per our database at Business Quant, Sotera Health's Depreciation and Depletion crashed by 453.76% in 2021 and then skyrocketed by 2897.79% in 2024.
  • Sotera Health's Depreciation and Depletion (Quarter) stood at $16.7 million in 2021, then decreased by 1.19% to $16.5 million in 2022, then grew by 25.21% to $20.7 million in 2023, then rose by 0.04% to $20.7 million in 2024, then rose by 9.86% to $22.7 million in 2025.
  • Its last three reported values are $22.7 million in Q3 2025, $23.1 million for Q2 2025, and $22.1 million during Q1 2025.